Analysis of antigenic determinant sites of influenza virus using epitope scanning method
表位扫描法分析流感病毒抗原决定簇位点
基本信息
- 批准号:05670287
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this study is to synthesize peptides continuously which cover antigenic region of the hemagglutinin (HA) protein of influenza virus, and determine the antigenic determinant sites of the HA protein recognized by the human serum antibody. Furtheremore, we will analyze the degree of immunogenicity of each antigenic determinant site. We have obtained the following results until now.1. Multipin peptide synthesis was done according to the amino acid sequence of the HA polypeptide of influenza virus A/Kamata/14/91 (H3N2). The peptides consisting of eight or ten amino acids were continuously synthesized skipping two amino acids, covering the amino acid seuences between 100 to 300 of the HA polypeptide. Five paired sera of the patients who were infected with influenza A (H3N2) during the 1990/91 influenza season were used. The identification and the degree of immunogenicity of the ocntinuous epitopes were analyzed by ELISA assay.2. Five sera obtained after postinfection had 4 to 32-fold increased HI titers compared to those of the sera obtained at early stage of infection. However, the latter sera except one had HI titers of 20 to 40. When peptide antigens consisting of eight amino acids were used, about 1/3 of the peptides reacted with paired sera at defferent degrees. In one case who had a low HI titer at earky stage of infectin, postinfection serum reacted specifically with a few peptides. However, we could not specify antigenic determinant sites. We further synthesized peptides consisting of 10 amino acids. This time, antigenic determinant sites became more specifically identified compared to those of 8 amino acids, but further experiments were necessary to get clearcut conclusions.3. Further analyzes with the selection of patient's sera, determination of the number of amino acids consisting of the peptides to get more specificity, or severe control to see the degree of antigenicity, and so on, remained to be done.
本研究的目的是连续合成覆盖流感病毒血凝素(HA)蛋白抗原区的多肽,并确定人血清抗体识别HA蛋白的抗原决定簇位点。进一步分析各抗原决定簇位点的免疫原性程度。到目前为止,我们已经得到了以下结果.根据流感病毒A/Kamata/14/91(H3 N2)的HA多肽的氨基酸序列进行多针肽合成。由8个或10个氨基酸组成的肽连续合成,跳过两个氨基酸,覆盖HA多肽的100至300之间的氨基酸序列。使用1990/91流感季节期间感染甲型流感(H3 N2)的患者的五对血清。采用ELISA法对所获得的连续表位进行鉴定,并分析其免疫原性.感染后获得的5份血清的HI滴度比感染早期获得的血清高4 ~ 32倍。然而,除一份外,后者血清的HI滴度为20至40。当使用由8个氨基酸组成的肽抗原时,约1/3的肽与配对血清有不同程度的反应。1例感染早期HI滴度低者,感染后血清与少数肽段特异性反应。然而,我们不能指定抗原决定簇位点。我们进一步合成了由10个氨基酸组成的肽。这一次,抗原决定簇位点变得比8个氨基酸的那些更特异性地鉴定,但需要进一步的实验来得到明确的结论。进一步的分析与患者的血清的选择,确定的氨基酸组成的肽的数量,以获得更多的特异性,或严格的控制,看看抗原性的程度,等等,仍然有待完成。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Morishita: "Host-specific hemagglutination of influerzaA (HlNl) Virus" Microbiology and Immunology. 37. 661-665 (1993)
T.Morishita:“甲型流感 (H1N1) 病毒的宿主特异性血凝”微生物学和免疫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Morita,T.,Kobayashi,s.,Miyake,TIshihara,Y,Nakagima,S,Nagima,k,: "Host-specific hemagglutination of influenza A(H1N1)virus" Microbiology and Immunology. 37. 661-665 (1993)
Morita,T.,Kobayashi,s.,Miyake,TIshihara,Y,Nakagima,S,Nagima,k,:“甲型H1N1流感病毒的宿主特异性血凝”微生物学和免疫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakao,H.,Nakajima,K.,and Nakajima,S.: "Location on the evolutionary trees of the nonstructural orotein(NS)and neuraminidaje(NA)genes of late humaninfilenzaA(H2N2)virus:parental irses of the NS and NA jenesf Hong Kong influenzaA(H3N2)viruses" Journal of Ge
Nakao,H.、Nakajima,K. 和 Nakajima,S.:“晚期人类甲型流感病毒 (H2N2) 病毒的非结构奥罗蛋白 (NS) 和神经氨酸酶 (NA) 基因在进化树上的位置:NS 和 NA 的亲本鸢尾花
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Takahashi: "The Substantia nigra is a major target for neurovirulent influenza A Virus" Journal of Experimental Medicine. (in press). (1995)
M.Takahashi:“黑质是神经毒性甲型流感病毒的主要目标”《实验医学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Nakao: "Location on the evolutionary trees of the NS and the NA genes of late human influenzaA (H2N2) Viruses" Journal of Geneval Virology. 74. 1667-1672 (1993)
H.Nakao:“晚期人类甲型流感 (H2N2) 病毒的 NS 和 NA 基因进化树上的位置”《日内瓦病毒学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAJIMA Setsuko其他文献
NAKAJIMA Setsuko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAJIMA Setsuko', 18)}}的其他基金
Formation of city image and urban reform by modern civil engineering projects
现代土木工程的城市形象塑造与城市改造
- 批准号:
22560641 - 财政年份:2010
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Genetic and biophysical mechanisms that control influenza virus cellular multiplicity of infection
控制流感病毒细胞感染多重性的遗传和生物物理机制
- 批准号:
10659426 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Unravelling highly pathogenic influenza virus emergence
揭开高致病性流感病毒出现的谜团
- 批准号:
10718091 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
- 批准号:
10678459 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Transcription, replication, trafficking and assembly of the influenza virus RNA genome
流感病毒RNA基因组的转录、复制、运输和组装
- 批准号:
MR/X008312/1 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Research Grant
Assessment of PilVax nasal vaccine for preventing influenza virus infection
PilVax 鼻疫苗预防流感病毒感染的评估
- 批准号:
22KF0065 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for JSPS Fellows
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Functional elucidation of influenza virus sialidase by intracellular enzymatic activity imaging probe.
通过细胞内酶活性成像探针阐明流感病毒唾液酸酶的功能。
- 批准号:
23K16306 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACCINE
用于广泛保护性流感病毒疫苗的多价 QS-18 蛋白纳米颗粒
- 批准号:
10933284 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Cell-free synthesis of influenza virus-like particles (VLPs) as prototyping platform for vaccine development and variant characterization
流感病毒样颗粒 (VLP) 的无细胞合成作为疫苗开发和变体表征的原型平台
- 批准号:
10648472 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Task V32: MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2
任务 V32:1 期和 2 期流感病毒人类挑战材料的制造
- 批准号:
10938084 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:














{{item.name}}会员




